EKF Diagnostics Holdings Plc Asset Resilience Ratio
EKF Diagnostics Holdings Plc asset resilience ratio. EKF Diagnostics Holdings Plc (EKF) has an Asset Resilience Ratio of -1.58% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EKF Diagnostics Holdings Plc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of EKF Diagnostics Holdings Plc (2009–2024)
Asset resilience ratio of EKF Diagnostics Holdings Plc from 2009 to 2024. This chart shows how EKF Diagnostics Holdings Plc's Asset Resilience Ratio has changed over time. Read EKF Diagnostics Holdings Plc debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down EKF Diagnostics Holdings Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EKF asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX-1.29 Million | -1.58% |
| Total Liquid Assets | GBX-1.29 Million | -1.58% |
Asset Resilience Insights
- Limited Liquidity: EKF Diagnostics Holdings Plc maintains only -1.58% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
EKF Diagnostics Holdings Plc Industry Peers by Asset Resilience Ratio
Compare EKF Diagnostics Holdings Plc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
TAIDOC TECHNOLOGY CORP
TW:4736 |
Medical Devices | 23.03% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
EKF Diagnostics Holdings Plc Asset Resilience Ratio by Year (2009–2024)
EKF Diagnostics Holdings Plc asset resilience ratio by year from 2009 to 2024. The table below shows the annual Asset Resilience Ratio data for EKF Diagnostics Holdings Plc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | -1.58% | GBX-1.29 Million ≈ $-156.83 |
GBX81.75 Million ≈ $9.95K |
-1.66pp |
| 2011-12-31 | 0.09% | GBX51.00K ≈ $6.21 |
GBX58.73 Million ≈ $7.15K |
-0.19pp |
| 2010-12-31 | 0.28% | GBX100.00K ≈ $12.17 |
GBX35.98 Million ≈ $4.38K |
-7.12pp |
| 2009-12-31 | 7.39% | GBX473.00K ≈ $57.55 |
GBX6.40 Million ≈ $778.33 |
-- |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more